HIV Drugs No Longer in Development

Show Archived (Historical) Articles

Overview

Failed Anti-HIV Drugs (Regularly Updated)
From aidsmap.com

Capravirine

Pfizer Drops Development of Antiretroviral Capravirine, Citing Lack of Efficacy in Trials (July 5, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

Lodenosine

Lodenosine Update (March 2000)
In What's New, from Project Inform
Safety Concerns Prompt Suspension of Lodenosine Clinical Trial (December 1999/January 2000)
In Positive Living, from AIDS Project Los Angeles
Lodenosine Study Suspended (October 1999)
In HIV Newsline, from San Francisco General Hospital

Othe Drugs

Incyte Halts Development of Promising New CCR5 Drug (April 10, 2008)
From Project Inform
GSK Discontinues Clinical Development of Investigational Protease Inhibitor Brecanavir (640385) (December 18, 2006)
To read PDF, click here
From GlaxoSmithKline
Development of DFC, an Investigational NRTI, Is Discontinued (April 4, 2006)
From The Body

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

HIV Antiretrovirals in Development: An Update From ICAAC 2009

Back From the Brink: A Blog Entry by Thomas DeLorenzo

World AIDS Day 2009: Home

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.